Rob Collin

Company: Astherna BV

Job title: Chief Scientific Officer

Seminars:

Advancing ASO Therapies for Ophthalmic Disorders: Addressing Challenges & Expanding Applications in Ophthalmology 9:00 am

Overview of antisense oligonucleotides (ASOs) and their role in treating ophthalmic disorders Exploring the potential of ASOs in broader applications beyond splicing modulation Overview of recent advancements in ASO design and delivery methods Highlighting efforts in developing functional assays and organoid models for assessing ASO efficacyRead more

day: Day One 11th

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.